Ara
Toplam kayıt 6, listelenen: 1-6
Is infertility a predictor of prostate cancer?
(Elsevier, 2021)
...
Moving away from systematic biopsies: Image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review
(Springer, 2021)
Objective To compare the detection rate of clinically significant cancer (CSCa) by magnetic resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) and to evaluate the role of MRI-TB as a ...
Prostate cancer multifocality, the index lesion, and the microenvironment
(Lippincott Williams & Wilkins, 2018)
Purpose of reviewMost of focal therapies has addressed index lesion as the targeted tumour focus to treat localized prostate cancer (PCa), a multifocal disease. The interaction between tumour foci and host cells creates a ...
Available evidence on HIFU for focal treatment of prostate cancer: A systematic review
(NLM (Medline), 2022)
PURPOSE: Prostate cancer (PCa) is the second most common oncologic disease among men. Radical treatment with curative intent provides good oncological results for PCa survivors, although definitive therapy is associated ...
Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies
(Nature Publishing Group, 2019)
Despite improvements in early detection and advances in treatment, patients with prostate cancer continue to die from their disease. Minimal residual disease after primary definitive treatment can lead to relapse and distant ...
Imaging and technologies for prostate cancer. Where are we now-where do we go?
(Springer, 2021)
We have been witnessing rapid advances in the diagnosis and treatment of prostate cancer. While some approaches have matured, others are still in their infancy. We have learned that Active Surveillance is safe in patients ...